Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Tanezumab

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Tanezumab?

Tanezumab is an investigational drug.

There have been 17 clinical trials for Tanezumab. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2016.

The most common disease conditions in clinical trials are Osteoarthritis, Osteoarthritis, Knee, and Low Back Pain. The leading clinical trial sponsors are Pfizer, Eli Lilly and Company, and Massachusetts General Hospital.

Recent Clinical Trials for Tanezumab
Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to SchwannomatosisPfizerPhase 2
Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to SchwannomatosisMassachusetts General HospitalPhase 2
Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical StudiesEli Lilly and CompanyPhase 3

See all Tanezumab clinical trials

Clinical Trial Summary for Tanezumab

Top disease conditions for Tanezumab
Top clinical trial sponsors for Tanezumab

See all Tanezumab clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.